166 related articles for article (PubMed ID: 38281819)
1. Detection of subclinical atrial fibrillation with cardiac implanted electronic devices: What decision making on anticoagulation after the NOAH and ARTESiA trials?
Boriani G; Gerra L; Mei DA; Bonini N; Vitolo M; Proietti M; Imberti JF
Eur J Intern Med; 2024 May; 123():37-41. PubMed ID: 38281819
[TBL] [Abstract][Full Text] [Related]
2. Direct Oral Anticoagulants for Stroke Prevention in Patients With Device-Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA Trials.
McIntyre WF; Benz AP; Becher N; Healey JS; Granger CB; Rivard L; Camm AJ; Goette A; Zapf A; Alings M; Connolly SJ; Kirchhof P; Lopes RD
Circulation; 2024 Mar; 149(13):981-988. PubMed ID: 37952187
[TBL] [Abstract][Full Text] [Related]
3. Probing oral anticoagulation in patients with atrial high rate episodes: Rationale and design of the Non-vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes (NOAH-AFNET 6) trial.
Kirchhof P; Blank BF; Calvert M; Camm AJ; Chlouverakis G; Diener HC; Goette A; Huening A; Lip GYH; Simantirakis E; Vardas P
Am Heart J; 2017 Aug; 190():12-18. PubMed ID: 28760205
[TBL] [Abstract][Full Text] [Related]
4. Rationale and Design of the Evaluation of Oral Anticoagulation for Reduction of Thrombo-embolism in Chinese Patients with Device-Detected Subclinical Atrial Fibrillation (ART-CAF) Trial: an Open-Label Registry-Based Clinical Trial.
Yang Y; Xu F; Tong J; Cai L; Jiang W; Sheng X; Pan Y; Jiang J; Zhang J; Jiang D; Zhao L; Fu G
Cardiovasc Drugs Ther; 2018 Aug; 32(4):389-396. PubMed ID: 30027309
[TBL] [Abstract][Full Text] [Related]
5. Atrial high-rate episodes: prevalence, stroke risk, implications for management, and clinical gaps in evidence.
Bertaglia E; Blank B; Blomström-Lundqvist C; Brandes A; Cabanelas N; Dan GA; Dichtl W; Goette A; de Groot JR; Lubinski A; Marijon E; Merkely B; Mont L; Piorkowski C; Sarkozy A; Sulke N; Vardas P; Velchev V; Wichterle D; Kirchhof P
Europace; 2019 Oct; 21(10):1459-1467. PubMed ID: 31377792
[TBL] [Abstract][Full Text] [Related]
6. What to do with device-detected atrial high-rate episodes: Summary of the evidences.
Özge Mert G; Kepez A; Uğur Mert K; Görenek B
Pacing Clin Electrophysiol; 2022 Feb; 45(2):250-261. PubMed ID: 34927268
[TBL] [Abstract][Full Text] [Related]
7. Physician decision making in anticoagulating atrial fibrillation: a prospective survey of a physician notification system for atrial fibrillation detected on cardiac implantable electronic devices of patients at increased risk of stroke.
Cloutier JM; Khoo C; Hiebert B; Wassef A; Seifer CM
Ther Adv Cardiovasc Dis; 2018 Apr; 12(4):113-122. PubMed ID: 29528778
[TBL] [Abstract][Full Text] [Related]
8. Atrial high-rate episodes and stroke prevention.
Camm AJ; Simantirakis E; Goette A; Lip GY; Vardas P; Calvert M; Chlouverakis G; Diener HC; Kirchhof P
Europace; 2017 Feb; 19(2):169-179. PubMed ID: 28172715
[TBL] [Abstract][Full Text] [Related]
9. The influence of atrial high-rate episodes on stroke and cardiovascular death: an update.
Toennis T; Bertaglia E; Brandes A; Dichtl W; Fluschnik N; de Groot JR; Marijon E; Mont L; Lundqvist CB; Cabanelas N; Dan GA; Lubinski A; Merkely B; Rajappan K; Sarkozy A; Velchev V; Wichterle D; Kirchhof P
Europace; 2023 Jul; 25(7):. PubMed ID: 37345804
[TBL] [Abstract][Full Text] [Related]
10. Role of cardiac electronic implantable device in the stratification and management of embolic risk of silent atrial fibrillation: are all atrial fibrillations created equal?
Di Cori A; Lilli A; Zucchelli G; Zaca V
Expert Rev Cardiovasc Ther; 2018 Mar; 16(3):175-181. PubMed ID: 29431527
[TBL] [Abstract][Full Text] [Related]
11. [Device-detected atrial arrhythmia - when is anticoagulation indicated?].
Almqvist M; Mattsson G; Magnusson P
Lakartidningen; 2019 Aug; 116():. PubMed ID: 31408188
[TBL] [Abstract][Full Text] [Related]
12. Anticoagulation in Patients with Atrial High-rate Episodes Detected by Cardiac Implantable Electronic Devices.
Spartalis M; Kontogiannis C; Spartalis E; Iliopoulos DC; Siasos G
Curr Pharm Des; 2024; 30(7):485-488. PubMed ID: 38343055
[TBL] [Abstract][Full Text] [Related]
13. Anticoagulation with edoxaban in patients with long atrial high-rate episodes ≥24 h.
Becher N; Toennis T; Bertaglia E; Blomström-Lundqvist C; Brandes A; Cabanelas N; Calvert M; Camm AJ; Chlouverakis G; Dan GA; Dichtl W; Diener HC; Fierenz A; Goette A; de Groot JR; Hermans ANL; Lip GYH; Lubinski A; Marijon E; Merkely B; Mont L; Ozga AK; Rajappan K; Sarkozy A; Scherr D; Schnabel RB; Schotten U; Sehner S; Simantirakis E; Vardas P; Velchev V; Wichterle D; Zapf A; Kirchhof P
Eur Heart J; 2024 Mar; 45(10):837-849. PubMed ID: 37956458
[TBL] [Abstract][Full Text] [Related]
14. Practice Variation in Anticoagulation Prescription and Outcomes After Device-Detected Atrial Fibrillation.
Perino AC; Fan J; Askari M; Heidenreich PA; Keung E; Raitt MH; Piccini JP; Ziegler PD; Turakhia MP
Circulation; 2019 May; 139(22):2502-2512. PubMed ID: 30880434
[TBL] [Abstract][Full Text] [Related]
15. Oral anticoagulation for subclinical atrial tachyarrhythmias detected by implantable cardiac devices: an international survey of the AF-SCREEN Group.
Boriani G; Healey JS; Schnabel RB; Lopes RD; Calkins H; Camm JA; Freedman B
Int J Cardiol; 2019 Dec; 296():65-70. PubMed ID: 31327519
[TBL] [Abstract][Full Text] [Related]
16. Clinical Impact of Oral Anticoagulation in Patients with Atrial High-rate Episodes.
Marinheiro R; Parreira L; Amador P; Lopes C; Fernandes A; Mesquita D; Farinha J; Fonseca M; Duarte T; Caria R
J Stroke Cerebrovasc Dis; 2019 Apr; 28(4):971-979. PubMed ID: 30642667
[TBL] [Abstract][Full Text] [Related]
17. Covert atrial fibrillation and atrial high-rate episodes as a potential cause of embolic strokes of undetermined source: Their detection and possible management strategy.
Tomita H; Sasaki S; Hagii J; Metoki N
J Cardiol; 2018 Jul; 72(1):1-9. PubMed ID: 29609876
[TBL] [Abstract][Full Text] [Related]
18. When to prescribe oral anticoagulation for patients with device-detected subclinical atrial fibrillation? Insights from the NOAH-AFNET 6 and ARTESiA trials.
McIntyre WF; Healey JS; Lopes RD
Eur J Intern Med; 2024 May; 123():52-54. PubMed ID: 38599924
[No Abstract] [Full Text] [Related]
19. Intermittent anticoagulation guided by continuous atrial fibrillation burden monitoring using dual-chamber pacemakers and implantable cardioverter-defibrillators: Results from the Tailored Anticoagulation for Non-Continuous Atrial Fibrillation (TACTIC-AF) pilot study.
Waks JW; Passman RS; Matos J; Reynolds M; Thosani A; Mela T; Pederson D; Glotzer TV; Zimetbaum P
Heart Rhythm; 2018 Nov; 15(11):1601-1607. PubMed ID: 29981863
[TBL] [Abstract][Full Text] [Related]
20. Subclinical Atrial Fibrillation: To Anticoagulate or Not?
Kommu S; Sharma PP
J Clin Med; 2024 May; 13(11):. PubMed ID: 38892946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
